Serinolamides and Lyngbyabellins from an Okeania sp Cyanobacterium Collected from the Red Sea

被引:24
|
作者
Petitbois, Julie G. [1 ]
Casalme, Loida O. [1 ]
Lopez, Julius Adam V. [1 ]
Alarif, Walied M. [3 ]
Abdel-Lateff, Ahmed [4 ,5 ]
Al-Lihaibi, Sultan S. [3 ]
Yoshimura, Erina [6 ]
Nogata, Yasuyuki [7 ]
Umezawa, Taiki [1 ,2 ]
Matsuda, Fuyuhiko [1 ,2 ]
Okino, Tatsufumi [1 ,2 ]
机构
[1] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan
[2] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan
[3] King Abdulaziz Univ, Fac Marine Sci, Dept Marine Chem, POB 80207, Jeddah 21589, Saudi Arabia
[4] King Abdulaziz Univ, Fac Pharm, Dept Nat Prod & Alternat Med, POB 80260, Jeddah 21589, Saudi Arabia
[5] Menia Univ, Fac Pharm, Dept Pharmacognosy, Al Minya 61519, Egypt
[6] CERES Inc, 1-4-5 Midori, Abiko, Chiba 2701153, Japan
[7] Cent Res Inst Elect Power Ind, Environm Sci Res Lab, Abiko, Chiba 2701194, Japan
来源
JOURNAL OF NATURAL PRODUCTS | 2017年 / 80卷 / 10期
关键词
MARINE CYANOBACTERIUM; DOLASTATIN; 16; MAJUSCULA; ACID;
D O I
10.1021/acs.jnatprod.7b00449
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
NMR-and MS-guided fractionation of an extract of an Okeania sp. marine cyanobacterium, collected from the Red Sea, led to the isolation of four new metabolites, including serinolamides C (1) and D (2) and lyngbyabellins O (3) and P (4), together with the three known substances lyngbyabellins F (5) and G (6) and dolastatin 16 (7). The planar structures of the new compounds were determined using NMR and MS analyses. The absolute configurations of 1 and 2 were determined by Marfey's analysis of their hydrolysates. The absolute configuration of 3 was ascertained by chiral-phase chromatography of degradation products, while that of 4 was determined by comparison to 3 and 5. The cytotoxic and antifouling activities of these compounds were evaluated using MCF7 breast cancer cells and Amphibalanus amphitrite larvae, respectively. Compounds 3, 4, and 7 exhibited strong antifouling activity, and 3 and 7 were not cytotoxic. A structure-activity relationship was observed for the cytotoxicity of the lyngbyabellins with the presence of a side chain (4 is more active than 3) leading to greater activity. For the antifouling activity, the acyclic form without a side chain (3) was the most active.
引用
收藏
页码:2708 / 2715
页数:8
相关论文
共 50 条
  • [1] Jizanpeptins, Cyanobacterial Protease Inhibitors from a Symploca sp Cyanobacterium Collected in the Red Sea
    Gallegos, David A.
    Sauri, Josep
    Cohen, Ryan D.
    Wan, Xuemei
    Videau, Patrick
    Vallota-Eastman, Alec O.
    Shaala, Lamiaa A.
    Youssef, Diaa T. A.
    Williamson, R. Thomas
    Martin, Gary E.
    Philmus, Benjamin
    Sikora, Aleksandra E.
    Ishmael, Jane E.
    McPhail, Kerry L.
    JOURNAL OF NATURAL PRODUCTS, 2018, 81 (06): : 1417 - 1425
  • [2] Bioactivities of Lyngbyabellins from Cyanobacteria of Moorea and Okeania Genera
    Fathoni, Imam
    Petitbois, Julie G.
    Alarif, Walied M.
    Abdel-Lateff, Ahmed
    Al-Lihaibi, Sultan S.
    Yoshimura, Erina
    Nogata, Yasuyuki
    Vairappan, Charles S.
    Sholikhah, Eti Nurwening
    Okino, Tatsufumi
    MOLECULES, 2020, 25 (17):
  • [3] Odoamide, a cytotoxic cyclodepsipeptide from the marine cyanobacterium Okeania sp.
    Sueyoshi, Kosuke
    Kaneda, Masato
    Sumimoto, Shinpei
    Oishi, Shinya
    Fujii, Nobutaka
    Suenaga, Kiyotake
    Teruya, Toshiaki
    TETRAHEDRON, 2016, 72 (35) : 5472 - 5478
  • [4] Ikoamide, an Antimalarial Lipopeptide from an Okeania sp. Marine Cyanobacterium
    Iwasaki, Keitaro
    Iwasaki, Arihiro
    Sumimoto, Shimpei
    Matsubara, Teruhiko
    Sato, Toshinori
    Nozaki, Tomoyoshi
    Saito-Nakano, Yumiko
    Suenaga, Kiyotake
    JOURNAL OF NATURAL PRODUCTS, 2020, 83 (02): : 481 - 488
  • [5] Ypaoamides B and C, Linear Lipopeptides from an Okeania sp Marine Cyanobacterium
    Sueyoshi, Kosuke
    Yamada, Miki
    Yamano, Aki
    Ozaki, Kaori
    Sumimoto, Shimpei
    Iwasaki, Arihiro
    Suenaga, Kiyotake
    Teruya, Toshiaki
    JOURNAL OF NATURAL PRODUCTS, 2018, 81 (04): : 1103 - 1107
  • [6] Isolation and Bioassay of Linear Veraguamides from a Marine Cyanobacterium (Okeania sp.)
    Parker, Stacy-Ann J.
    Hough, Andrea
    Wright, Thomas
    Lax, Neil
    Faruk, Asef
    Fofie, Christian K.
    Simcik, Rebekah D.
    Cavanaugh, Jane E.
    Kolber, Benedict J.
    Tidgewell, Kevin J.
    MOLECULES, 2025, 30 (03):
  • [7] Kohamamides A, B, and C, Cyclic Depsipeptides from an Okeania sp Marine Cyanobacterium
    Iwasaki, Arihiro
    Shiota, Ikuma
    Sumimoto, Shimpei
    Matsubara, Teruhiko
    Sato, Toshinori
    Suenaga, Kiyotake
    JOURNAL OF NATURAL PRODUCTS, 2017, 80 (06): : 1948 - 1952
  • [8] Irijimasides A-E, Macrolide Glycosides from an Okeania sp. Marine Cyanobacterium
    Yamano, Aki
    Natsume, Noriyuki
    Yamada, Miki
    Sumimoto, Shimpei
    Iwasaki, Arihiro
    Suenaga, Kiyotake
    Teruya, Toshiaki
    JOURNAL OF NATURAL PRODUCTS, 2020, 83 (05): : 1585 - 1591
  • [9] Isolation and Total Synthesis of Mabuniamide, a Lipopeptide from an Okeania sp. Marine Cyanobacterium
    Ozaki, Kaori
    Iwasaki, Arihiro
    Sezawa, Dai
    Fujimura, Haruka
    Nozaki, Tomoyoshi
    Saito-Nakano, Yumiko
    Suenaga, Kiyotake
    Teruya, Toshiaki
    JOURNAL OF NATURAL PRODUCTS, 2019, 82 (10): : 2907 - 2915
  • [10] Amantamide C, an Antitrypanosomal Linear Lipopeptide from a Marine Okeania sp. Cyanobacterium
    Watanabe, Natsumi
    Jeelani, Ghulam
    Nozaki, Tomoyoshi
    Iwasaki, Arihiro
    ACS OMEGA, 2024, 9 (34): : 36795 - 36801